Curex

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

• Compounded semaglutideCompounded · not FDA-approved
• Compounded tirzepatideCompounded · not FDA-approved
• Compounded oral dissolving tablets (semaglutide / tirzepatide)Compounded · not FDA-approved

What they publish

Curex publishes 3 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee

None — states 'no membership fees ever' (as published)

Medication cost

From $149 and from $199 depending on plan, published as including both prescription and medication (as published)

Introductory offer

Not publicly disclosed on the pages we captured.

Insurance

States no insurance is needed.

HSA / FSA

Not publicly disclosed on the pages we captured.

Consultation process

Not publicly disclosed on the pages we captured.

Eligibility

Not publicly disclosed on the pages we captured.

Lab work

Not publicly disclosed on the pages we captured.

Pharmacy fulfilment

Not publicly disclosed on the pages we captured.

Shipping

Not publicly disclosed on the pages we captured.

Support services

Not publicly disclosed on the pages we captured.

Cancellation

Not publicly disclosed on the pages we captured.

Refunds

Not publicly disclosed on the pages we captured.

What stands out

• The 'no membership fee ever' structure removes the two-part pricing that makes most of this market hard to compare.
• Offers oral dissolving tablet formulations of compounded GLP-1s, which is a less common delivery route.
• All products published were compounded; no FDA-approved route appeared on the page we captured.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

• Oral compounded GLP-1 formulations are further from the studied products than compounded injectables. Ask what evidence supports the specific formulation.
• Ask which pharmacy compounds the product and whether it is a 503A or 503B facility.
• Confirm whether the 'from' price holds as your dose escalates.

Frequently asked